Jasper TherapeuticsJSPR
13F holders, Q2 2026 (June 30)At the end of Q2 2026, 45 institutions reported holding Jasper Therapeutics Inc. (JSPR) in their 13F filings, down 13 from Q1 2026. 3 opened new positions and 16 sold out. The largest holders were Velan Capital Investment Management LP ($1.1M), Acorn Capital Advisors, LLC ($604K) and Kingdon Capital Management, L.L.C. ($569K). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Jasper Therapeutics Inc.
- CUSIP
- 471871202
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $18K |
| Exits | 16 | $1.4M |
All 13F filers, Q1 2026 → Q2 2026: 795,404 shares bought and 4,606,759 shares sold, net −3,811,355 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 45 holders
| Velan Capital Investment Management LP | 0.69% | No change | 2,668,395 | $1.1M |
| Acorn Capital Advisors, LLC | 0.16% | Add +1.9% | 1,438,159 | $604K |
| Kingdon Capital Management, L.L.C. | 0.08% | No change | 1,352,106 | $569K |
| Vanguard Capital Management LLC | 0.00% | Reduce -0.1% | 1,172,021 | $493K |
| Rock Springs Capital Management LP | 0.02% | No change | 1,100,726 | $463K |
| Carlyle Group Inc. | 0.00% | No change | 1,066,189 | $449K |
| Gsa Capital Partners LLP | 0.01% | Add +2701.8% | 534,697 | $225K |
| Millennium Management | 0.00% | Reduce -69.9% | 486,933 | $205K |
| Lion Point Capital, LP | 0.94% | No change | 465,000 | $196K |
| Geode Capital Management, LLC | 0.00% | Reduce -17.0% | 263,808 | $111K |
| Renaissance Technologies | 0.00% | Add +34.0% | 237,900 | $100K |
| BlackRock, Inc. | 0.00% | Reduce -29.9% | 169,627 | $71K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 149,943 | $63K |
| ADAR1 Capital Management, LLC | 0.00% | No change | 140,000 | $59K |
| Quarry LP | 0.01% | No change | 131,529 | $55K |
| Jane Street Group, LLC | 0.00% | Add +375.1% | 101,743 | $43K |
| UBS Group AG | 0.00% | Reduce -27.6% | 58,759 | $25K |
| Jain Global LLC | 0.00% | Add +184.0% | 51,185 | $22K |
| Osaic Holdings, Inc. | 0.00% | Add +12.2% | 45,850 | $19K |
| State Street Corp. | 0.00% | No change | 44,699 | $19K |
| Northern Trust Corp. | 0.00% | Add +21.1% | 41,882 | $18K |
| Diker Management LLC | 0.01% | No change | 35,000 | $15K |
| Qube Research & Technologies Ltd | 0.00% | New | 33,722 | $14K |
| XTX Topco Ltd | 0.00% | Reduce -15.3% | 33,406 | $14K |
| Simplex Trading, LLC | 0.00% | Reduce -2.3% | 28,591 | $12K |
| Ikarian Capital, LLC | 0.00% | No change | 24,093 | $10K |
| Group One Trading LLC | 0.00% | Add +2152.0% | 19,930 | $8K |
| Rehmann Capital Advisory Group | 0.00% | No change | 15,300 | $6K |
| Sequent Planning LLC | 0.00% | No change | 14,900 | $6K |
| Bank of America Corp. | 0.00% | Reduce -95.2% | 14,192 | $6K |
| Ieq Capital, LLC | 0.00% | Reduce -73.7% | 13,538 | $6K |
| Engineers Gate Manager LP | 0.00% | Reduce -50.3% | 12,989 | $5K |
| LPL Financial LLC | 0.00% | No change | 12,250 | $5K |
| SG Americas Securities, LLC | 0.00% | New | 10,556 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +48.1% | 9,336 | $4K |
| Morgan Stanley | 0.00% | Reduce -99.9% | 1,724 | $726 |
| Arax Advisory Partners | 0.00% | New | 573 | $241 |
| Federated Hermes, Inc. | 0.00% | Reduce -95.1% | 189 | $80 |
| National Bank of Canada | 0.00% | No change | 160 | $63 |
| BNP Paribas Financial Markets | 0.00% | No change | 141 | $59 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -1.5% | 64 | $27 |
| Jones Financial Companies LLLP | 0.00% | No change | 50 | $17 |
| JPMorgan Chase & Co. | 0.00% | No change | 9 | $4 |
| Royal Bank of Canada | 0.00% | Reduce -66.7% | 40 | $0 |
| Caitong International Asset Management Co., Ltd | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is JSPR's weight in each manager's 13F, not the share of Jasper Therapeutics Inc. the manager owns.